Airgas USA LLC
Form 483 issued February 18, 2022 · Salt Lake City, Utah
- Inspection
- Feb 15 – Feb 18, 2022
- Observations
- 2
- Pages
- 4
- FEI number
- 1717226
In short: On February 18, 2022, FDA issued a Form 483 with 2 observations to Airgas USA LLC in Salt Lake City, Utah (FEI 1717226) after an inspection that ran Feb 15 – Feb 18, 2022. Most observations concern packaging & labeling; the most-cited regulation is 21 CFR 211.130 (packaging and labeling operations).
At a glance
2 of 2 observations on this 483 concern packaging & labeling.
Most cited: 21 CFR 211.130(a) (1×) · 211.122(d) (1×)
What FDA observed
Preview: the opening words of each observation- 01
There is insufficient physical or spatial separation from operations and other drug products to…
- 02
Access to the storage area for labels and labeling materials is not…
This inspection in context
Questions about this 483
What did FDA find at Airgas USA LLC?
FDA listed 2 observations on this Form 483, mostly about packaging & labeling. The most-cited regulation is 21 CFR 211.130 (packaging and labeling operations). The opening words of each observation are shown on this page.
When was Airgas USA LLC inspected by FDA?
The inspection ran Feb 15 – Feb 18, 2022, and the Form 483 is dated February 18, 2022.
How do I get the full Form 483 for Airgas USA LLC?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.